Overview

Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya disease and stroke patients
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Treatments:
Xenon